Compounds of the formula (I): in which R, R
1
and R
2
are as defined in the description, the use thereof for the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions comprising them, and . processes for the preparation of these compounds. Compounds of formula (I) are activators of PPARα and PPARα isoforms.
公式(I)的化合物:其中R,R1和R2如描述中所定义,其用于治疗血脂异常,动脉硬化和糖尿病,包含它们的制药组合物以及制备这些化合物的过程。公式(I)的化合物是
PPARα和
PPARα同工型的激活剂。